SCHEMBL17664442

SCHEMBL17664442

CC(C)(C)ONC(C(N)=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.45
CTSK P43235 1/20 0.45
EPHX1 P07099 2/20 0.43
ATM Q13315 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
PDGFRA P16234 1/20 0.42
MAPK1 P28482 1/20 0.42
MAPKAPK2 P49137 1/20 0.42
RPS6KA1 Q15418 1/20 0.42
AURKB Q96GD4 1/20 0.42
CSNK1G1 Q9HCP0 1/20 0.42
GPR88 Q9GZN0 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 1/20 0.41
ACP3 P15309 1/20 0.39
ALOX5 P09917 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3212595 0.78 CTSK (0.63) CTSSCTSKATMGPR88
SCHEMBL5743400 0.78 CTSK (0.63) CTSSCTSKATMGPR88
SCHEMBL3212586 0.78 CTSK (0.63) CTSSCTSKATMGPR88
SCHEMBL18120821 0.77 SLC6A4 (0.49) EPHX1ATMCYP3A4CYP2C9PDGFRA
SCHEMBL18120825 0.77 SLC6A4 (0.49) EPHX1ATMCYP3A4CYP2C9PDGFRA
Tert-Butyl Formate SCHEMBL28841632 0.77 CNR1 (0.41) CTSSCTSKATMCYP3A4CYP2C9
SCHEMBL5170849 0.75 TACR3 (0.46) EPHX1CYP3A4CYP2C9MAPK1GPR88
SCHEMBL19652060 0.75 TACR3 (0.46) EPHX1CYP3A4CYP2C9MAPK1GPR88
SCHEMBL10090088 0.74 LMNA (0.44) EPHX1CYP3A4CYP2C9PDGFRAMAPK1
SCHEMBL22502277 0.74 LMNA (0.49) EPHX1CYP3A4CYP2C9PDGFRAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016053855-A1 SPHINGOSINE-1-PHOSPATE RECEPTOR MODULATORS FOR TREATMENT OF CARDIOPULMONARY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2016-04-07 WO disclosed